A Phase III, Double-Blind. Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients > 18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy.
- Wei, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research